Closed
Contract for the Provision for the Manufacture of Vaccine Antigen
Deadline:16 Oct 2025, 00:00 GMT+1
Tender information
TED EUDublin, Ireland
- Type
- 16
- Procedure
- open
- Ref. number
- 634422-2025
- Estimated value
- 100,000 EUR
- CPV
- 33651600
UCD has developed a series of bacterial antigens which have proven effective in proof-of-concept studies and which the aim is to further develop and translate to humans. The lead target antigen is 22 kDa cytosolic bacter…